Skip to main content

Webinar: Why psychedelic medicine is coming in from the cold

Why psychedelic medicine is coming in from the cold

Webinar: Why psychedelic medicine is coming in from the cold

Prof David Nutt is Professor of Neuropsychopharmacology and Director of the Neuropsychopharmacology Unit in the Division of Brain Sciences, Imperial College, London. David is currently Chair of DrugScience (formally the Independent Scientific Committee on Drugs (ISCD). Previously he has been President of the European Brain Council (EBC) the European College of Neuropsychopharmacology (ECNP), the British Neuroscience Association (BNA) and the British Association of Psychopharmacology (BAP). In addition he is a Fellow of the Royal Colleges of Physicians and of Psychiatrists, the British Pharmacological Society and a Fellow of the Academy of Medical Sciences. He is also the UK Director of the European Certificate and Masters in Affective Disorders Courses and a member of the International Centre for Science in Drug Policy. He has edited the Journal of Psychopharmacology for over two decades and acts as the psychiatry drugs advisor to the British National Formulary. He has published over 500 original research papers, a similar number of reviews and books chapters, eight government reports on drugs and 40 books.

Video